Cell Cryopreservation Market: By Product Type, By Cell Types, By Application, By End Users, Hospitals and Clinics) and By Geography and forecast to 2030.

Cell Cryopreservation Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Cryoprotectant Agents, Equipment), By Cell Types (Stem cells, Oocytes and embryotic cells, Sperm cells, Hepatocytes, Other Cell Types), By Application (Drug Discovery and Development, Regenerative Medicine, Organ Transplantation, Clinical Research, Other Applications), By End Users (Research Organizations, Biotech/ Pharmaceutical Companies, Contract Research Organizations (CROs), Hospitals and Clinics) and By Region (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) and forecast to 2030.

Cell Cryopreservation Market size was valued at US$ 9,746.3 million in 2023 and is poised to grow at a CAGR of 21.3% from 2024-2030. Cell cryopreservation is a process used to preserve cells, tissues, or any other biological constructs by cooling them to very low temperatures. At such low temperatures, any biological activity is effectively halted. Cryoprotectants are substances used to protect biological tissue from freezing damage. They work by preventing the formation of ice crystals. Once frozen, cells are stored at cryogenic temperatures, usually in liquid nitrogen at temperatures of -196°C. Rising awareness and adoption of fertility preservation techniques, especially among women wishing to delay childbearing or facing fertility issues, are driving the demand for cryopreservation solutions. According to the Society for Assisted Reproductive Technology (SART), in the United States alone, the number of egg freezing cycles increased from 7,193 in 2016 to 12,438 in 2020, reflecting a growth rate of approximately 73% over that period. Moreover, advances in stem cell therapies and regenerative medicine, the establishment of new biobanks and the rising demand for personalized medicine are the main drivers of this market. In addition, WHO also emphasis the importance of the cell cryopreservation and best practices. During COVID-19, the worthiness of the cell cryopreservation is noted as this technology helped in maintaining vaccine production. The most important and crucial constraints of this market is the initial investment and ongoing maintenance costs for cryopreservation equipment and storage facilities. Also concerns from the recipient side is the cryoprotectant toxicity. Some cryoprotectants, like DMSO, can be toxic to cells at certain concentrations, posing challenges in optimizing protocols for different cell types. Every market has it’s own challenges, as this one has are regulatory and ethical issues faced by the companies, storage and transportation of the preserved cell samples.

Recent Development In The Cell Cryopreservation Market :

  • In June 2023, BioLife Solutions, Inc. announced the launch of a new large-capacity controlled-rate freezer (CRF) to expand its CRF product line.
  • In 2022, AMSBIO has introduced 'STEM-CELLBANKER EX,' a state-of-the-art cryopreservation solution designed to accelerate the development of cell therapy products.
  • In March 2022, Eppendorf Corporate redesigned the CryoCubeF570 ULT freezer with improved cooling liquids and insulation foam

Cell Cryopreservation Market Summary

Study Period

2024– 2030

Base Year

2023

CAGR

N/A

Largest Market

North America

Fastest Growing Market

Asia pacific

Cell Cryopreservation Market Dynamics

Increase in the research and application in regenerative medicine, stem cell therapies and fertility preservation techniques are the first and dominant application of this market. The new trend in Cell Cryopreservation market is continuous technological advancements in automated cryopreservation systems, rise in personalised medicine has drastically increased the market share as people find it convenient. The introduction of AI in pharmacogenomic diagnostics is also an emerging trend for the Global Cell Cryopreservation market. The ongoing research and development efforts aimed at creating less toxic and more effective cryoprotectant formulations. Increased government funding and support for stem cell research and regenerative medicine present significant opportunities for market growth. Healthcare advancements in regions like Asia-Pacific present lucrative market expansion for companies.

Cell Cryopreservation Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024– 2030

Market Size in 2023

US$ 9,746.3 million

By Product

  • Cryoprotectant agents
    • Dimethyl sulfoxide (DMSO)
    • Ethylene glycol
    • Glycerol
    • Other agents
  • Equipment
    • Freezers
    • Incubators
    • Liquid nitrogen supply tanks
    • Cryopreservation consumables

By Cell Types

  • Stem cells
  • Oocytes and embryotic cells
  • Sperm cells
  • Hepatocytes
  • Other cell types

By Application

  • Drug discovery and development
  • Regenerative medicine
  • Organ transplantation
  • Clinical research
  • Other applications

By End User

  • Research Organizations
  • Biotech/ Pharmaceutical Companies
  • Contract research organizations (CROs)
  • Hospitals and clinics

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.

Download Free Sample Report

Frequently Asked Questions

Cell Cell Cryopreservation Market size was valued at US$ 9,746.3 million in 2023 and is poised to grow at a CAGR of 21.3% from 2024-2030.

Major companies operating within the Cell Cryopreservation Market are GE Healthcare, Helmer Scientific, Lonza Group Ltd., Cardinal Health, Inc., Merck KGaA, STEMCELL Technologies Inc., BioLife Solutions, Inc., Cryolife, Inc., Organ Recovery Systems Inc., Thermo Fisher Scientific Inc., Custom Biogenic Systems, Sartorius AG, Takara Bio Inc., Chart Industries, Inc., Biocision, LLC and Other.

The growing burden of chronic diseases, technological advancements in stem cell therapies, adaptation of personalised healthcare and pharmaceutical R&D investments are the major factors that are driving the growth of the global market by incidence.

North America is projected to lead the global Cell Cryopreservation market as the presence of robust research and healthcare infrastructure and substantial funding compared the rest of the world.

Cryoprotectant agents section have the largest share in Cell Cryopreservation Market by product type, because of the price of each dictates.

Stem Cells and eggs (ovum) has the largest share in Cell Cryopreservation Market by application.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Cell Cryopreservation Market Introduction 
2.1.Global Cell Cryopreservation Market  - Taxonomy
2.2.Global Cell Cryopreservation Market  - Definitions
2.2.1.Product
2.2.2.Cell Type 
2.2.3.Application
2.2.4.End Users
2.2.5.Region
3. Global Cell Cryopreservation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Cell Cryopreservation Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cell Cryopreservation Market  By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Cryoprotectant agents
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Equipment
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Global Cell Cryopreservation Market  By Cell Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Stem cells
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Oocytes and embryotic cells
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Sperm cells
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Hepatocytes
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Other cell types
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Cell Cryopreservation Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Drug discovery and development
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Regenerative medicine
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Organ transplantation
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Clinical research
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Other applications
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. Global Cell Cryopreservation Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Research Organizations
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Biotech/ Pharmaceutical Companies
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Contract research organizations (CROs)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Hospitals and clinics
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Global Cell Cryopreservation Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Cell Cryopreservation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Cryoprotectant agents
10.1.2.Equipment
10.2.  Cell Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Stem cells
10.2.2.Oocytes and embryotic cells
10.2.3.Sperm cells
10.2.4.Hepatocytes
10.2.5.Other cell types
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Drug discovery and development
10.3.2.Regenerative medicine
10.3.3.Organ transplantation
10.3.4.Clinical research
10.3.5.Other applications
10.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Research Organizations
10.4.2.Biotech/ Pharmaceutical Companies
10.4.3.Contract research organizations (CROs)
10.4.4.Hospitals and clinics
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Cell Cryopreservation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Cryoprotectant agents
11.1.2.Equipment
11.2.  Cell Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Stem cells
11.2.2.Oocytes and embryotic cells
11.2.3.Sperm cells
11.2.4.Hepatocytes
11.2.5.Other cell types
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Drug discovery and development
11.3.2.Regenerative medicine
11.3.3.Organ transplantation
11.3.4.Clinical research
11.3.5.Other applications
11.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Research Organizations
11.4.2.Biotech/ Pharmaceutical Companies
11.4.3.Contract research organizations (CROs)
11.4.4.Hospitals and clinics
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Cell Cryopreservation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Cryoprotectant agents
12.1.2.Equipment
12.2.  Cell Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Stem cells
12.2.2.Oocytes and embryotic cells
12.2.3.Sperm cells
12.2.4.Hepatocytes
12.2.5.Other cell types
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Drug discovery and development
12.3.2.Regenerative medicine
12.3.3.Organ transplantation
12.3.4.Clinical research
12.3.5.Other applications
12.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Research Organizations
12.4.2.Biotech/ Pharmaceutical Companies
12.4.3.Contract research organizations (CROs)
12.4.4.Hospitals and clinics
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Cell Cryopreservation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Cryoprotectant agents
13.1.2.Equipment
13.2.  Cell Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Stem cells
13.2.2.Oocytes and embryotic cells
13.2.3.Sperm cells
13.2.4.Hepatocytes
13.2.5.Other cell types
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Drug discovery and development
13.3.2.Regenerative medicine
13.3.3.Organ transplantation
13.3.4.Clinical research
13.3.5.Other applications
13.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Research Organizations
13.4.2.Biotech/ Pharmaceutical Companies
13.4.3.Contract research organizations (CROs)
13.4.4.Hospitals and clinics
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Cell Cryopreservation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Cryoprotectant agents
14.1.2.Equipment
14.2.  Cell Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Stem cells
14.2.2.Oocytes and embryotic cells
14.2.3.Sperm cells
14.2.4.Hepatocytes
14.2.5.Other cell types
14.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Drug discovery and development
14.3.2.Regenerative medicine
14.3.3.Organ transplantation
14.3.4.Clinical research
14.3.5.Other applications
14.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Research Organizations
14.4.2.Biotech/ Pharmaceutical Companies
14.4.3.Contract research organizations (CROs)
14.4.4.Hospitals and clinics
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Asymptote (a part of GE Healthcare)
15.2.2.BioLife Solutions, Inc.
15.2.3.CellGenix GmbH
15.2.4.Chart Industries, Inc.
15.2.5.CHT (Cellular Highways Technologies)
15.2.6.Creative Biolabs
15.2.7.Cryoport, Inc.
15.2.8.Eppendorf Corporate
15.2.9.HiMedia Laboratories
15.2.10.Lonza
15.2.11.Merck Group
15.2.12.Miltenyi Biotech
15.2.13.NexImmune
15.2.14.PromoCell GmbH
15.2.15.Sartorius AG
15.2.16.STEMCELL Technologies Inc.
15.2.17.Thermo Fisher Scientific Inc.
15.2.18.VWR International, LLC (a part of Avantor)
 15.2.18.VWR International, LLC (a part of Avantor)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Asymptote (a part of GE Healthcare)
  • BioLife Solutions, Inc.
  • CellGenix GmbH
  • Chart Industries, Inc.
  • CHT (Cellular Highways Technologies)
  • Creative Biolabs
  • Cryoport, Inc.
  • Eppendorf Corporate
  • HiMedia Laboratories
  • Lonza
  • Merck Group
  • Miltenyi Biotech
  • NexImmune
  • PromoCell GmbH
  • Sartorius AG
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC (a part of Avantor)
  • WAK-Chemie Medical GmbH

Related Industry Reports